Canada authorizes second vaccine to fight the pandemic
Canada’s health regulator has authorized a second COVID-19 vaccine
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Canada’s health regulator on Wednesday authorized a second COVID-19 vaccine.
Health Canada said the vaccine from U.S. biotech firm Moderna is safe for use in the country and Moderna said it anticipates starting shipments to Canada within 48 hours.
It follows the Dec. 9 approval of the Pfizer-BioNTech vaccine.
Up to 168,000 doses of the Moderna shot are set to arrive by the end of December, and 2 million by the end of March.
Canada is to get 40 million doses of Moderna’s vaccine in 2021, enough to vaccinate 20 million people, or about two-thirds of the Canadian adult population
Moderna’s vaccine uses the same basic technology as Pfizer-BioNTech’s shot. Most traditional vaccines use dead or weakened virus, but the new vaccines use snippets of COVID-19′s genetic code to train the immune system to detect and fight the virus. Both require two doses; Moderna’s are four weeks apart.
The Moderna vaccine needs to be stored at regular freezer temperatures, but not the ultra-cold required for Pfizer-BioNTech’s shot.